Saudi Arabia Pharmaceuticals and Healthcare Report Q4 2014

Date: October 1, 2014
Pages: 115
Price:
US$ 1,295.00
Publisher: Business Monitor International
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: SF2DFB27D71EN
Leaflet:

Download PDF Leaflet

Includes 3 FREE quarterly updates

BMI View: Saudi Arabia's economic, demographic, epidemiological and political factors will shape the provision of healthcare across the nation. Healthcare spending will be greatly boosted by government initiatives. The new health projects will increase access to healthcare and provide revenue-earning opportunities for drugmakers, medical device companies and healthcare service providers. The government's planned privatisation of the healthcare industry will increase investment in the sector, with greater transparency attracting foreign companies.

Headline Expenditure Projections
  • Pharmaceuticals: SAR22.70bn (USD6.06bn) in 2013 to SAR24.79bn (USD6.62bn) in 2014; +9.2% in both local currency and US dollar terms. Forecast unchanged from Q314.
  • Healthcare: SAR94.20bn (USD25.15bn) in 2013 to SAR102.58bn (USD27.39bn) in 2014; +8.9% in both local currency and US dollar terms. Forecast unchanged from Q314.
BMI Industry View
SWOT
Political
Economic
Business Environment
Industry Forecast
Pharmaceutical Market Forecast
  Table: Pharmaceutical Sales, Historical Data And Forecasts (Saudi Arabia 2010-2018)
Healthcare Market Forecast
  Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Saudi Arabia 2010-2018)
  Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Saudi Arabia 2010-2018)
  Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Saudi Arabia 2010-2018)
Saudi Arabia
  Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Saudi Arabia 2010-2018)
Patented Drug Market Forecast
  Table: Patented Drug Market Indicators, Historical Data And Forecasts (Saudi Arabia 2010-2018)
Generic Drug Market Forecast
  Table: Generic Drug Market Indicators, Historical Data And Forecasts (Saudi Arabia 2010-2018)
OTC Medicine Market Forecast
  Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Saudi Arabia 2010-2018)
Pharmaceutical Trade Forecast
  Table: Pharmaceutical Trade Data And Forecasts (Saudi Arabia 2012-2018)
  Table: Pharmaceutical Trade Data And Forecasts local currency (Saudi Arabia 2012-2018)
Other Healthcare Data
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
  Table: BMI AND BLOOMBERG CONSENSUS* FORECASTS FOR BRENT, USD/BBL
  Table: Economic Activity (Saudi Arabia 2009-2018)
Industry Risk Reward Ratings
Middle East & Africa Risk/Reward Ratings
Saudi Arabia Risk/Reward Ratings
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Non-Communicable Diseases
Healthcare Sector
Healthcare Sector Developments
Healthcare Sector Funding
Private Healthcare Sector
Primary Healthcare Provision
Secondary Healthcare Provision
Health Insurance
Information Technology (IT) in Healthcare
Research And Development (R&D)
Biotechnology
Clinical Trials
Regulatory Development
Regional Regulatory Developments
Free Trade Agreements
Intellectual Property Regime
IP Deficiencies
Counterfeit and Unregistered Drugs
OTC Drug Market
Pricing Regime
Pricing System Reform
Tendering Procedures
Reimbursement Regime
Competitive Landscape
Pharmaceutical Industry
Domestic Industry
Foreign Industry
Pharmaceutical Sector Developments
Pharmaceutical Wholesale
Pharmaceutical Retail
Company Profile
SPIMACO
Saudi Arabian Japanese Pharmaceutical (SAJA)
TABUK Pharmaceutical Manufacturing
Jamjoom Pharma
GlaxoSmithKline
Novartis
Merck & Co
Pfizer
Sanofi
Hikma Pharmaceuticals Plc
Demographic Forecast
  Table: Saudi Arabia's Population By Age Group, 1990-2020 ('000)
  Table: Saudi Arabia's Population By Age Group, 1990-2020 (% of total)
  Table: Saudi Arabia's Key Population Ratios, 1990-2020
  Table: Saudi Arabia's Rural And Urban Population, 1990-2020
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Ratings Methodology
Ratings Overview
  Table: Pharmaceutical Risk/Reward Ratings Indicators
Indicator Weightings
OTC Healthcare in Saudi Arabia to 2014 US$ 495.00 Jul, 2010 · 168 pages

Ask Your Question

Saudi Arabia Pharmaceuticals and Healthcare Report Q4 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: